Related Products

Growthink’s Ultimate
Business Plan Template

Our proven, fill-in-the-blanks business plan template allows you to quickly write your own business plan.

$97
Learn More

Raise Money From Venture Capitalists

Growthink’s Step-By-Step Guide to Raising Venture Capital presents our proven system for raising venture capital for your business on favorable terms.

$97
Learn More

Raise Money from Angels

Growthink’s Step-By-Step Guide to Raising Capital from Angel Investors will guide you through the process of raising money from individual “angel” investors..

$97
Learn More

Alternative/Creative
Financing Sources

Growthink’s Definitive Guide to Creative & Alternative Financing Sources presents 28 proven creative and alternative sources of capital to fund your new or growing business.

$97
Learn More

Raise Money from Grants

Growthink’s Step-By-Step Guide to Raising Capital from Grants will guide you through the process of winning grants to fund your business.

$97
Learn More

Raise Money from Loans

Growthink’s Step by Step Guide to Raising Capital From Banks and SBA Lenders will teach you how to quickly and easily get the right SBA and/or bank loan to fund your business.

$97
Learn More

Market Research for Your Business Plan

Growthink’s exclusive report, “How to Quickly, Easily & Expertly Conduct Zero-Cost Market Research For Your Business” teaches you how to quickly conduct industry, competitive and customer research for your business plan.

$39
Learn More

Growthink University

Learn how to complete your business plan, raise capital and grow your business.

$97 - $147/mo.
Learn More

 
Growthink Blog
Join Our Newsletter

Growthink Client Dakim Secures $10M+ in Series C Funding

Print
Categories:

We were thrilled to see that Dakim has raised $10.6 million in Series C financing, in a transaction led by Galen Partners.

Dakim is an innovated provider of brain fitness technology to improve the quality of life for Alzheimer's patients.

Growthink assisted Dakim in the drafting of their business plan, and in assessing the market for non-drug Alzheimer's-related products and services -- so we're especially proud of the company's success. We're happy that we've been able to play a role in their growth.


Share this article:


Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
8 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.